HCW Biologics Inc. (HCWB)
Develops immune-boosting drugs to treat chronic inflammation and autoimmune diseases.
$2.59-0.02%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-89.6%
The outlook
HCWB is trading near its 52-week low, well below both its 50- and 200-day moving averages, reflecting weak recent momentum. Analyst coverage shows a wide gap—the average price target sits roughly 1,061% above the current price, though this appears based on thin or speculative forecasts. The overall sentiment leans bearish despite the bullish target disconnect.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range3% of the way from its 52-week low to high
Price targetAvg target +1061% vs current price
Market cap
$4.1M
52-wk high
$44.10
52-wk low
$1.50
50-day avg
$7.13
200-day avg
$8.54
Trailing P/E
—